Code of Virginia
Chapter 34 - Drug Control Act
§ 54.1-3423. Board to issue registration unless inconsistent with public interest; authorization to conduct research; application and fees

A. The Board shall register an applicant to manufacture or distribute controlled substances included in Schedules I through V unless it determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the Board shall consider the following factors:
1. Maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, or industrial channels;
2. Compliance with applicable state and local law;
3. Any convictions of the applicant under any federal and state laws relating to any controlled substance;
4. Past experience in the manufacture or distribution of controlled substances, and the existence in the applicant's establishment of effective controls against diversion;
5. Furnishing by the applicant of false or fraudulent material in any application filed under this chapter;
6. Suspension or revocation of the applicant's federal registration to manufacture, distribute, or dispense controlled substances as authorized by federal law; and
7. Any other factors relevant to and consistent with the public health and safety.
B. Registration under subsection A does not entitle a registrant to manufacture and distribute controlled substances in Schedule I or II other than those specified in the registration.
C. Practitioners must be registered to conduct research or laboratory analysis with controlled substances in Schedules II through VI, tetrahydrocannabinol, or marijuana. Practitioners registered under federal law to conduct research with Schedule I substances, other than tetrahydrocannabinol, may conduct research with Schedule I substances within this Commonwealth upon furnishing the evidence of that federal registration.
D. The Board may register other persons or entities to possess controlled substances listed on Schedules II through VI upon a determination that (i) there is a documented need, (ii) the issuance of the registration is consistent with the public interest, (iii) the possession and subsequent use of the controlled substances complies with applicable state and federal laws and regulations, and (iv) the subsequent storage, use, and recordkeeping of the controlled substances will be under the general supervision of a licensed pharmacist, practitioner of medicine, osteopathy, podiatry, dentistry, or veterinary medicine as specified in the Board's regulations. The Board shall consider, at a minimum, the factors listed in subsection A of this section in determining whether the registration shall be issued. Notwithstanding the exceptions listed in § 54.1-3422 A, the Board may mandate a controlled substances registration for sites maintaining certain types and quantities of Schedules II through VI controlled substances as it may specify in its regulations. The Board shall promulgate regulations related to requirements or criteria for the issuance of such controlled substances registration, storage, security, supervision, and recordkeeping.
E. The Board may register a public or private animal shelter as defined in § 3.2-6500 to purchase, possess, and administer certain Schedule II through VI controlled substances approved by the State Veterinarian for the purpose of euthanizing injured, sick, homeless, and unwanted domestic pets and animals and to purchase, possess, and administer certain Schedule VI drugs and biological products for the purpose of preventing, controlling, and treating certain communicable diseases that failure to control would result in transmission to the animal population in the shelter. Controlled substances used for euthanasia shall be administered only in accordance with protocols established by the State Veterinarian and only by persons trained in accordance with instructions by the State Veterinarian. The list of Schedule VI drugs and biological products used for treatment and prevention of communicable diseases within the shelter shall be determined by the supervising veterinarian of the shelter and the drugs and biological products shall be administered only pursuant to written protocols established or approved by the supervising veterinarian of the shelter and only by persons who have been trained in accordance with instructions established or approved by the supervising veterinarian. The shelter shall maintain a copy of the approved list of drugs and biological products, written protocols for administering, and training records of those persons administering drugs and biological products on the premises of the shelter.
F. The Board may register a crisis stabilization unit established pursuant to § 37.2-500 or 37.2-601 and licensed by the Department of Behavioral Health and Developmental Services to maintain a stock of Schedule VI controlled substances necessary for immediate treatment of patients admitted to the crisis stabilization unit, which may be accessed and administered by a nurse pursuant to a written or oral order of a prescriber in the absence of a prescriber. Schedule II through Schedule V controlled substances shall only be maintained if so authorized by federal law and Board regulations.
G. The Board may register an entity at which a patient is treated by the use of instrumentation and diagnostic equipment through which images and medical records may be transmitted electronically for the purpose of establishing a bona fide practitioner-patient relationship and is prescribed Schedule II through VI controlled substances when such prescribing is in compliance with federal requirements for the practice of telemedicine and the patient is not in the physical presence of a practitioner registered with the U.S. Drug Enforcement Administration. In determining whether the registration shall be issued, the Board shall consider (i) the factors listed in subsection A, (ii) whether there is a documented need for such registration, and (iii) whether the issuance of the registration is consistent with the public interest.
H. Applications for controlled substances registration certificates and renewals thereof shall be made on a form prescribed by the Board and such applications shall be accompanied by a fee in an amount to be determined by the Board.
I. Upon (i) any change in ownership or control of a business, (ii) any change of location of the controlled substances stock, (iii) the termination of authority by or of the person named as the responsible party on a controlled substances registration, or (iv) a change in the supervising practitioner, if applicable, the registrant or responsible party shall immediately surrender the registration. The registrant shall, within 14 days following surrender of a registration, file a new application and, if applicable, name the new responsible party or supervising practitioner.
1972, c. 798, § 54-524.47:3; 1978, c. 833; 1980, c. 288; 1988, c. 765; 1996, cc. 468, 496; 1998, c. 490; 2009, cc. 149, 169; 2010, c. 28; 2014, c. 148; 2017, cc. 58, 110; 2018, c. 774; 2020, c. 941.

Structure Code of Virginia

Code of Virginia

Title 54.1 - Professions and Occupations

Chapter 34 - Drug Control Act

§ 54.1-3400. Citation

§ 54.1-3401. Definitions

§ 54.1-3401.1. Repealed

§ 54.1-3402. Repealed

§ 54.1-3403. Chapter not applicable to economic poisons

§ 54.1-3404. Inventories of controlled substances required of certain persons; contents and form of record

§ 54.1-3405. Access to and copies of records; inspections

§ 54.1-3406. Records confidential; disclosure of information about violations of federal law

§ 54.1-3407. Analysis of controlled substances

§ 54.1-3408. Professional use by practitioners

§ 54.1-3408.01. Requirements for prescriptions

§ 54.1-3408.02. Transmission of prescriptions

§ 54.1-3408.03. Dispensing of therapeutically equivalent drug product permitted

§ 54.1-3408.04. Dispensing of interchangeable biosimilars permitted

§ 54.1-3408.05. Use of FDA-approved substance upon publication of final rule

§ 54.1-3408.1. Prescription in excess of recommended dosage in certain cases

§ 54.1-3408.2. Failure to report administration or dispensing of or prescription for controlled substances; report required; penalty

§ 54.1-3408.3. Certification for use of cannabis oil for treatment

§ 54.1-3408.4. Expired

§ 54.1-3408.5. Epinephrine required in certain public places

§ 54.1-3409. Professional use by veterinarians

§ 54.1-3410. When pharmacist may sell and dispense drugs

§ 54.1-3410.1. Requirements for radiopharmaceuticals

§ 54.1-3410.2. Compounding; pharmacists' authority to compound under certain conditions; labeling and record maintenance requirements

§ 54.1-3411. When prescriptions may be refilled

§ 54.1-3411.1. Prohibition on returns, exchanges, or re-dispensing of drugs; exceptions

§ 54.1-3411.2. Prescription drug disposal programs

§ 54.1-3411.2:1. Guidelines for disposal of unused drugs

§ 54.1-3412. Date of dispensing; initials of pharmacist; automated data processing system

§ 54.1-3413. Manufacturing and administering Schedule I drugs

§ 54.1-3414. Official orders for Schedule II drugs

§ 54.1-3415. Distribution of drugs in Schedules II through VI by manufacturers and wholesalers

§ 54.1-3415.1. Delivery of medical devices on behalf of a medical equipment supplier

§ 54.1-3416. No prescription for preparations listed pursuant to Schedule V

§ 54.1-3417. Disposing of stocks of Schedules II through V drugs

§ 54.1-3418. Sale of aqueous or oleaginous solutions

§ 54.1-3419. Dispensing of insulin preparations

§ 54.1-3420. Distribution of certain drugs; written request or confirmation of receipt

§ 54.1-3420.1. Identification required for filling prescriptions

§ 54.1-3420.2. Delivery of prescription drug order

§ 54.1-3421. New drugs

§ 54.1-3422. Controlled substances registration certificate required in addition to other requirements; exemptions

§ 54.1-3423. Board to issue registration unless inconsistent with public interest; authorization to conduct research; application and fees

§ 54.1-3424. Suspension or revocation of registration, license or permit; limitation to particular controlled substance; controlled substances placed under seal; sale of perishables and forfeiture; notification to DEA

§ 54.1-3425. Repealed

§ 54.1-3426. Regulations for special packaging

§ 54.1-3427. Dispensing drugs without safety closure container

§ 54.1-3428. Dissemination of information

§ 54.1-3429. Revocation of permit issued to manufacturer, wholesaler or distributor

§ 54.1-3430. Display of permit; permits nontransferable; renewal

§ 54.1-3431. Admission into evidence of certain certificates of analysis

§ 54.1-3432. Supervision by pharmacist

§ 54.1-3433. Certain advertising and signs unlawful

§ 54.1-3434. Permit to conduct pharmacy

§ 54.1-3434.01. Notice of pharmacy closing; change of ownership; penalty

§ 54.1-3434.02. Automated drug dispensing systems

§ 54.1-3434.03. Continuous quality improvement program

§ 54.1-3434.04. Automatic review of certain case decisions

§ 54.1-3434.05. Permit to act as an outsourcing facility

§ 54.1-3434.1. Nonresident pharmacies to register with Board

§ 54.1-3434.2. Permit to be issued

§ 54.1-3434.3. Denial, revocation, suspension of registration, summary proceedings

§ 54.1-3434.4. Prohibited acts

§ 54.1-3434.5. Nonresident outsourcing facilities to register with the Board

§ 54.1-3435. License to act as wholesale distributor; renewal; fee

§ 54.1-3435.01. Registration of nonresident wholesale distributors; renewal; fee

§ 54.1-3435.02. Certain permitted pharmacies and medical equipment suppliers exempted

§ 54.1-3435.1. Denial, revocation, and suspension of license, permit, or registration of certain entities

§ 54.1-3435.2. Permit to act as medical equipment supplier; storage; limitation; regulations

§ 54.1-3435.3. Inspection and audit

§ 54.1-3435.3:1. Registration of nonresident medical equipment suppliers; renewal; fee

§ 54.1-3435.4. Permit to act as warehouser; regulations

§ 54.1-3435.4:01. Registration to act as a nonresident warehouser; regulations

§ 54.1-3435.4:1. Permitting of third-party logistics provider; renewal

§ 54.1-3435.4:2. Registration of nonresident third-party logistics provider; renewal

§ 54.1-3435.5. Repealed

§ 54.1-3436. Repealed

§ 54.1-3436.1. Prescription drug price transparency

§ 54.1-3437. Permit to manufacture drugs

§ 54.1-3437.1. Limited permit for repackaging drugs

§ 54.1-3438. Manufacturing, etc., of drugs or proprietary medicines, to be supervised by pharmacist

§ 54.1-3439. Application for nonrestricted manufacturing permit; fee

§ 54.1-3440. Persons to whom nonrestricted permit is granted

§ 54.1-3441. Restricted manufacturing permit; application; fee; separate application and permit for each place of manufacturing

§ 54.1-3442. When permit not to be granted; regulations

§ 54.1-3442.01. Registration of nonresident manufacturer; renewal

§ 54.1-3442.02. Prescription drug price transparency

§ 54.1-3442.1. Definitions

§ 54.1-3442.2. Eligibility for expanded access to investigational drugs, biological products, and devices; written, informed consent to treatment

§ 54.1-3442.3. Expanded access to investigational drugs, biological products, or devices; cost; insurance coverage

§ 54.1-3442.4. Limitation of liability

§ 54.1-3442.5. Definitions

§ 54.1-3442.6. Permit to operate pharmaceutical processor or cannabis dispensing facility

§ 54.1-3442.7. Dispensing cannabis products; report

§ 54.1-3442.8. Criminal liability; exceptions

§ 54.1-3443. Board to administer article

§ 54.1-3444. Controlled substances included by whatever name designated

§ 54.1-3445. Placement of substance in Schedule I

§ 54.1-3446. Schedule I

§ 54.1-3447. Placement of substance in Schedule II

§ 54.1-3448. Schedule II

§ 54.1-3449. Placement of substance in Schedule III

§ 54.1-3450. Schedule III

§ 54.1-3451. Placement of substance in Schedule IV

§ 54.1-3452. Schedule IV

§ 54.1-3453. Placement of substance in Schedule V

§ 54.1-3454. Schedule V

§ 54.1-3455. Schedule VI

§ 54.1-3456. Controlled substance analog

§ 54.1-3456.1. Drugs of concern

§ 54.1-3457. Prohibited acts

§ 54.1-3458. Violations

§ 54.1-3459. Tagging of adulterated or misbranded drugs, devices, or cosmetics; condemnation; destruction; expenses

§ 54.1-3460. Poisonous or deleterious substance, or color additive

§ 54.1-3461. Adulterated drug or device

§ 54.1-3462. Misbranded drug or device

§ 54.1-3463. Exemption of drugs dispensed by filling or refilling prescription

§ 54.1-3464. Adulterated cosmetics

§ 54.1-3465. Misbranded cosmetics

§ 54.1-3466. Possession or distribution of controlled paraphernalia; definition of controlled paraphernalia; evidence; exceptions

§ 54.1-3467. Distribution of hypodermic needles or syringes, gelatin capsules, quinine or any of its salts

§ 54.1-3468. Conditions to dispensing device, item, or substance; records

§ 54.1-3469. Storage, usage, and disposition of controlled paraphernalia

§ 54.1-3470. Obtaining controlled paraphernalia by fraud, etc.

§ 54.1-3471. Issuance of permits to certain persons other than registered pharmacists

§ 54.1-3472. Article inapplicable to certain persons